Principal Financial Group’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15M Sell
1,072,983
-8,595
-0.8% -$120K 0.01% 1022
2025
Q1
$14.7M Sell
1,081,578
-49,385
-4% -$671K 0.01% 1036
2024
Q4
$23M Sell
1,130,963
-107,513
-9% -$2.19M 0.01% 768
2024
Q3
$36.1M Buy
1,238,476
+149,939
+14% +$4.37M 0.02% 575
2024
Q2
$25.3M Sell
1,088,537
-33,999
-3% -$789K 0.02% 728
2024
Q1
$23M Buy
1,122,536
+48,832
+5% +$1M 0.01% 828
2023
Q4
$23M Buy
1,073,704
+393,626
+58% +$8.45M 0.01% 794
2023
Q3
$14M Sell
680,078
-6,414
-0.9% -$132K 0.01% 1022
2023
Q2
$20.3M Buy
686,492
+197,531
+40% +$5.83M 0.01% 837
2023
Q1
$11.3M Sell
488,961
-37,498
-7% -$864K 0.01% 1195
2022
Q4
$14.6M Sell
526,459
-19,412
-4% -$540K 0.01% 1026
2022
Q3
$16.8M Buy
545,871
+278,139
+104% +$8.54M 0.01% 889
2022
Q2
$7.88M Sell
267,732
-1,272
-0.5% -$37.4K 0.01% 1377
2022
Q1
$8.65M Sell
269,004
-61,271
-19% -$1.97M 0.01% 1457
2021
Q4
$14.7M Buy
330,275
+26,448
+9% +$1.18M 0.01% 1166
2021
Q3
$15.3M Sell
303,827
-25,517
-8% -$1.29M 0.01% 1140
2021
Q2
$25.8M Sell
329,344
-8,223
-2% -$645K 0.02% 761
2021
Q1
$19.3M Buy
337,567
+130,063
+63% +$7.43M 0.01% 944
2020
Q4
$17.4M Buy
207,504
+4,959
+2% +$415K 0.01% 867
2020
Q3
$7.26M Buy
202,545
+523
+0.3% +$18.7K 0.01% 1262
2020
Q2
$4.89M Sell
202,022
-2,231
-1% -$53.9K ﹤0.01% 1435
2020
Q1
$3.58M Sell
204,253
-20,656
-9% -$362K ﹤0.01% 1419
2019
Q4
$3.92M Buy
224,909
+6,146
+3% +$107K ﹤0.01% 1594
2019
Q3
$3.35M Sell
218,763
-1,354
-0.6% -$20.7K ﹤0.01% 1625
2019
Q2
$4.57M Buy
220,117
+33,357
+18% +$693K ﹤0.01% 1558
2019
Q1
$4.34M Buy
186,760
+810
+0.4% +$18.8K ﹤0.01% 1589
2018
Q4
$3.84M Sell
185,950
-17
-0% -$351 ﹤0.01% 1590
2018
Q3
$4.04M Buy
185,967
+3,247
+2% +$70.6K ﹤0.01% 1654
2018
Q2
$2.79M Buy
182,720
+53,820
+42% +$821K ﹤0.01% 1710
2018
Q1
$2.54M Sell
128,900
-51,869
-29% -$1.02M ﹤0.01% 1707
2017
Q4
$2.83M Buy
+180,769
New +$2.83M ﹤0.01% 1705